Bioethics News

Researchers Synthesize Hybrid Molecule That Delivers a Blow to Malignant Cells

April 4, 2016

(Nanowerk) – A new hybrid molecule developed in the lab at the NYU Tandon School of Engineering shows promise for treating breast cancer by serving as a “shipping container” for cytotoxic — or cell-destroying — chemotherapeutic agents. The protein/polymer-gold nanoparticle (P-GNP) composite can load up with these drugs, carry them to malignant cells, and unload them where they can do the most damage with the least amount of harm to the patient.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.